APA

Dupont E., Andersen A., Boas J., Boisen E., Borgmann R., Helgetveit A. C., Kjaer M. O., Kristensen T. N., Mikkelsen B., Pakkenberg H., Presthus J., Stien R., Worm-Petersen J. & Buch D. (19961112). Sustained-release Madopar HBS compared with standard Madopar in the long-term treatment of de novo parkinsonian patients. : Acta neurologica Scandinavica.

Chicago

Dupont E, Andersen A, Boas J, Boisen E, Borgmann R, Helgetveit A C, Kjaer M O, Kristensen T N, Mikkelsen B, Pakkenberg H, Presthus J, Stien R, Worm-Petersen J and Buch D. 19961112. Sustained-release Madopar HBS compared with standard Madopar in the long-term treatment of de novo parkinsonian patients. : Acta neurologica Scandinavica.

Harvard

Dupont E., Andersen A., Boas J., Boisen E., Borgmann R., Helgetveit A. C., Kjaer M. O., Kristensen T. N., Mikkelsen B., Pakkenberg H., Presthus J., Stien R., Worm-Petersen J. and Buch D. (19961112). Sustained-release Madopar HBS compared with standard Madopar in the long-term treatment of de novo parkinsonian patients. : Acta neurologica Scandinavica.

MLA

Dupont E, Andersen A, Boas J, Boisen E, Borgmann R, Helgetveit A C, Kjaer M O, Kristensen T N, Mikkelsen B, Pakkenberg H, Presthus J, Stien R, Worm-Petersen J and Buch D. Sustained-release Madopar HBS compared with standard Madopar in the long-term treatment of de novo parkinsonian patients. : Acta neurologica Scandinavica. 19961112.